Assignee
KAHR MEDICAL LTD
IL·10 granted patents·12 pending applications·16 citations·filing 2013–2025
Top patents by PatentIndex Score
22 records- 0191US11130796B2SIRPalpha-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Sep 28, 2021·6 cites·11 claims
- 0289US10040841B2Stable form of signal converting protein fusion proteins, and methods of use and preparation thereofKAHR MEDICAL LTD·Filed 2013·Granted Aug 7, 2018·8 cites·10 claims
- 0384US12331098B2SIRPalpha-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Granted Jun 17, 2025·0 cites·20 claims
- 0482US11702458B2PD1-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Jul 18, 2023·2 cites·24 claims
- 0579US2025026809A1SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2024·Application pending·0 cites
- 0678US2025304653A1SIRPalpha-41BBL FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2025·Application pending·0 cites
- 0774US11897937B2SIRPalpha-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2021·Granted Feb 13, 2024·0 cites·11 claims
- 0873US12134638B2SIRPalpha-4-1BBL variant fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2019·Granted Nov 5, 2024·0 cites·10 claims
- 0971US2024010700A1Pd1-41bbl fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Application pending·0 cites
- 1069US2023220040A1Pd1-cd70 fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Application pending·0 cites
- 1164US2025163133A1SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2025·Application pending·0 cites
- 1264US2022204586A1SIRP alpha-CD70 FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2022·Application pending·0 cites
- 1359US11566060B2PD1-CD70 fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Jan 31, 2023·0 cites·7 claims
- 1459US11299530B2SIRP alpha-CD70 fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Apr 12, 2022·0 cites·7 claims
- 1558US2025051410A1Lilrb polypeptides and uses thereofKAHR MEDICAL LTD·Filed 2022·Application pending·0 cites
- 1655US10000549B2Compositions and methods for treatment of hematological malignanciesKAHR MEDICAL LTD·Filed 2016·Granted Jun 19, 2018·0 cites·22 claims
- 1753US2019016782A1Stable form of signal converting protein fusion proteins, and methods of use and preparation thereofKAHR MEDICAL LTD·Filed 2018·Application pending·0 cites
- 1852US2024076346A1Type i membrane proteins heterodimers and methods of use thereofKAHR MEDICAL LTD·Filed 2021·Application pending·0 cites
- 1951US12286466B2PD1-4-1BBL variant fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2019·Granted Apr 29, 2025·0 cites·13 claims
- 2050US2022267409A1Heterodimers and methods of use thereofKAHR MEDICAL LTD·Filed 2020·Application pending·0 cites
- 2146US2023048719A1Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of sameKAHR MEDICAL LTD·Filed 2020·Application pending·0 cites
- 2246US2023048361A1Methods of culturing t cells and uses of sameKAHR MEDICAL LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KAHR MEDICAL LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →